/Investor DB

Amboy Street Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Granata Biogranata.bioinJan 2024 · $14M

Granata Bio is a US-based biopharmaceutical company focused on reproductive health and fertility, in-licensing IVF medications used outside the US to develop and commercialize them in North America.

BiotechDigital HealthFemTechHealthtechDuxbury, US

Evan Sussman(Chief Executive Officer & Co-Founder)inMarc Chung(Co-Founder)inSarah Faranda(Co-Founder & Chief Development Officer)inDave Paller(CFO & Co-Founder)inSteve Medeiros(Chief Operating Officer)inZeb Younes(Chief Regulatory Officer, CMC)in

Co-investorsAlumni VenturesGaingelsGV (Google Ventures)Mana VenturesStrawberry Creek Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.